Medicare's 3 year limit on post-transplant immunosuppressive drugs

A lot has been written about this, here's yet another story that puts a personal edge on a systematic problem and a big waste of taxpayer dollars through a false economy: Medicare disserves younger kidney-transplant patients by DR. JANANI RANGASWAMI, FOR THE INQUIRER